DCN Dx specializes in the contract development of rapid point of care tests. We offer a variety of services and products that assist our clients in the design and development of user-centric, high performing diagnostic devices. Contract development of rapid immunoassays is at the core of all that we do at DCN Dx. We focus on lateral flow, flow through, and microfuidic formats. Our staff has unparalleled experience in developing assays with tough specifications, regarding high sensitivity, quantification, multiplexing and reader integration. Our ISO 9001:2015 compliant development process allows for close integration of assay and device development pathways, which ensures the best chance of commercial success for the product. As well as developing the assay itself, DCN Dx's integrated engineering team will design, develop and integrate your entire device. The engineers work closely with our scientists to create cassettes and sample handling devices that enhance the performance of your assay and meet all end-user specifications. We deliver the product, not just the parts. DCN Dx also offers a variety of products and services to assist our clients at any stage of development, including: - Custom, private education and training courses in lateral flow technology, during which we teach the details of how to develop and manufacture rapid assays. - Consulting services to assist with any aspect of rapid assay development, manufacturing, regulation and commercialization. - Custom protein-protein, protein-particle, small molecule-protein and small molecule- particle conjugations. - Lateral flow material starter kits, conjugation kits, reagents, cassettes and materials for use during rapid assay development. DCN Dx represents a single source that can help you manage and deliver completely validated assay platforms. CONTACT US: www.dcndx.com info@dcndx.com (760) 804-3886
| Website | http://www.dcndx.com |
| Revenue | $8.5 million |
| Funding | $350000 |
| Employees | 86 (68 on RocketReach) |
| Founded | 2005 |
| Address | 3193 Lionshead Ave Suite 200, Carlsbad, California 92010, US |
| Phone | +1 856-231-9922 |
| Industry | Biotechnology Research, Business Services General, Development of lateral flow immunoassays, Business Services, Quantitative, reader based lateral flow assay development, Education and Training in Lateral Flow Technology, Custom protein, particle and small molecule conjugation, Consulting services, Manufacturing transfer services |
| Web Rank | 5 Million |
| Keywords | Fluorescent Strip Reader Now Diagnostics, Dcn Diagnostics, Gold Nanoparticles, Training On Lateral Flow Assay India, Dcn Lateral Logo |
| Competitors | Siemens Healthineers, Roche, Thermo Fisher Scientific, Abbott, BD, Danaher Corporation, PerkinElmer, Inc., Bio-Rad Laboratories, Genetix, MediWise Pty Ltd +38 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 807 Companies, SIC Code 8071 Companies |
| NAICS | NAICS Code 621 Companies, NAICS Code 62 Companies, NAICS Code 6215 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 62151 Companies |
Looking for a particular DCN Dx employee's phone or email?
The DCN Dx annual revenue was $8.5 million in 2026.
Patrick Vaughan is the COO of DCN Dx.
68 people are employed at DCN Dx.
DCN Dx is based in Carlsbad, California.
The NAICS codes for DCN Dx are [621, 62, 6215, 54, 541, 62151].
The SIC codes for DCN Dx are [80, 807, 8071].